カルナバイオサイエンスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2010/10/05 | 39,950 | 39,950 | 38,900 | 39,000 | -1,450 | -3.6% | 226 |
| 2010/10/04 | 41,400 | 42,200 | 40,300 | 40,450 | -1,800 | -4.3% | 104 |
| 2010/10/01 | 41,650 | 42,450 | 41,500 | 42,250 | -350 | -0.8% | 70 |
| 2010/09/30 | 42,300 | 42,700 | 42,200 | 42,600 | +250 | +0.6% | 74 |
| 2010/09/29 | 42,550 | 43,400 | 42,200 | 42,350 | -1,500 | -3.4% | 96 |
| 2010/09/28 | 42,200 | 43,950 | 42,000 | 43,850 | -850 | -1.9% | 105 |
| 2010/09/27 | 45,200 | 45,200 | 43,000 | 44,700 | -200 | -0.4% | 106 |
| 2010/09/24 | 45,000 | 45,000 | 43,000 | 44,900 | -100 | -0.2% | 74 |
| 2010/09/22 | 45,800 | 46,500 | 43,900 | 45,000 | -600 | -1.3% | 156 |
| 2010/09/21 | 44,500 | 45,900 | 42,800 | 45,600 | +1,800 | +4.1% | 178 |
| 2010/09/17 | 41,750 | 43,800 | 41,750 | 43,800 | +2,000 | +4.8% | 101 |
| 2010/09/16 | 41,900 | 42,650 | 41,350 | 41,800 | +100 | +0.2% | 76 |
| 2010/09/15 | 41,300 | 42,000 | 41,250 | 41,700 | -50 | -0.1% | 39 |
| 2010/09/14 | 41,700 | 42,000 | 41,200 | 41,750 | -350 | -0.8% | 81 |
| 2010/09/13 | 41,600 | 42,500 | 41,250 | 42,100 | +100 | +0.2% | 87 |
| 2010/09/10 | 42,400 | 43,000 | 41,800 | 42,000 | +300 | +0.7% | 79 |
| 2010/09/09 | 44,000 | 46,100 | 41,700 | 41,700 | -1,600 | -3.7% | 452 |
| 2010/09/08 | 41,100 | 43,300 | 40,600 | 43,300 | +2,250 | +5.5% | 153 |
| 2010/09/07 | 40,500 | 42,900 | 40,300 | 41,050 | +650 | +1.6% | 175 |
| 2010/09/06 | 40,100 | 40,500 | 40,000 | 40,400 | +350 | +0.9% | 117 |
| 2010/09/03 | 40,500 | 41,050 | 40,050 | 40,050 | -150 | -0.4% | 149 |
| 2010/09/02 | 40,450 | 40,600 | 40,000 | 40,200 | -150 | -0.4% | 96 |
| 2010/09/01 | 40,050 | 40,700 | 39,850 | 40,350 | +150 | +0.4% | 276 |
| 2010/08/31 | 42,050 | 42,950 | 40,200 | 40,200 | -3,200 | -7.4% | 213 |
| 2010/08/30 | 44,100 | 44,100 | 42,700 | 43,400 | -700 | -1.6% | 87 |
| 2010/08/27 | 42,700 | 44,100 | 42,400 | 44,100 | ±0 | ±0% | 49 |
| 2010/08/26 | 47,000 | 47,000 | 44,000 | 44,100 | -2,350 | -5.1% | 108 |
| 2010/08/25 | 45,000 | 49,000 | 43,000 | 46,450 | -750 | -1.6% | 481 |
| 2010/08/24 | 41,500 | 48,400 | 41,100 | 47,200 | +5,800 | +14% | 428 |
| 2010/08/23 | 40,800 | 41,900 | 40,800 | 41,400 | +600 | +1.5% | 60 |
| 2010/08/20 | 40,500 | 42,000 | 40,000 | 40,800 | +400 | +1% | 120 |
| 2010/08/19 | 40,000 | 40,400 | 39,250 | 40,400 | +250 | +0.6% | 46 |
| 2010/08/18 | 40,000 | 40,300 | 39,800 | 40,150 | +150 | +0.4% | 19 |
| 2010/08/17 | 39,800 | 41,450 | 39,600 | 40,000 | -950 | -2.3% | 64 |
| 2010/08/16 | 40,300 | 41,550 | 39,600 | 40,950 | +1,100 | +2.8% | 102 |
| 2010/08/13 | 40,500 | 41,500 | 39,750 | 39,850 | -150 | -0.4% | 51 |
| 2010/08/12 | 39,000 | 40,000 | 38,100 | 40,000 | ±0 | ±0% | 143 |
| 2010/08/11 | 40,000 | 40,100 | 39,350 | 40,000 | +250 | +0.6% | 61 |
| 2010/08/10 | 40,000 | 40,400 | 39,700 | 39,750 | -150 | -0.4% | 82 |
| 2010/08/09 | 41,000 | 41,000 | 39,600 | 39,900 | -1,450 | -3.5% | 80 |
| 2010/08/06 | 40,500 | 41,400 | 40,100 | 41,350 | +1,050 | +2.6% | 74 |
| 2010/08/05 | 40,300 | 41,000 | 40,300 | 40,300 | ±0 | ±0% | 98 |
| 2010/08/04 | 40,300 | 41,000 | 40,150 | 40,300 | -900 | -2.2% | 66 |
| 2010/08/03 | 40,800 | 41,350 | 40,500 | 41,200 | -300 | -0.7% | 98 |
| 2010/08/02 | 42,200 | 42,200 | 40,700 | 41,500 | -750 | -1.8% | 117 |
| 2010/07/30 | 42,800 | 43,500 | 41,100 | 42,250 | -1,150 | -2.6% | 152 |
| 2010/07/29 | 43,700 | 43,700 | 42,700 | 43,400 | -400 | -0.9% | 30 |
| 2010/07/28 | 43,700 | 43,950 | 42,600 | 43,800 | +300 | +0.7% | 57 |
| 2010/07/27 | 44,500 | 44,500 | 43,000 | 43,500 | -1,500 | -3.3% | 85 |
| 2010/07/26 | 46,200 | 46,200 | 44,700 | 45,000 | +50 | +0.1% | 81 |
3351～
3400
件表示中 / 3477件
類似銘柄と比較する
現在ご覧いただいている「カルナバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| カルナバイオ | 39,500円 | -43.1% | - | 0.00% | - | 1.84倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
| ＶＩＳ | 111,300円 | +87.8% | +265.7% | 0.00% | 66.85倍 | 4.58倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
| カイオム | 12,800円 | +2.6% | - | 0.00% | - | 6.33倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
| 日ケミファ | 158,000円 | +2.5% | - | 3.16% | 95.01倍 | 0.31倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
| メドレックス | 16,600円 | +1424.1% | - | 0.00% | - | 3.61倍 |
|
経皮吸収型製剤技術に強い創薬ベンチャー。治験は米国で。先端分野マイクロニードルに挑戦 |
市場注目の銘柄
チャート関連のコラム
